Apply on company website Cambridge, Massachusetts, United States Hybrid Full-time

Cognito Therapeutics is hiring an Associate Director/Director, Scientific Communications

Associate Director/Director, Scientific Communications, Cognito Therapeutics, Inc. Location: Cambridge, MA, USA, Full-time Company Description Cognito Therapeutics, Inc. is a venture-backed (Morningside Ventures, FoundersX, IAG, Starbloom) late clinical stage company translating scientific findings from MIT into therapeutic approaches for brain health, including Alzheimer’s disease and other neurodegenerative conditions. We were awarded a Breakthrough designation by the FDA in December 2020 based upon our feasibility data that showed our therapy’s strong safety profile and a notable preservation of cognition and function in patients with mild-to-moderate Alzheimer’s. We completed enrollment in our pivotal study, HOPE, in June 2025 and expect to release topline data from the trial in summer 2026. We are a fast-moving, highly motivated team of innovators with the ambitious goal of helping millions of patients and caregivers around the world who are impacted by neurodegenerative conditions. With our patented brain stimulation technology, we are committed to developing convenient, safe and effective neuroprotective therapies to improve brain health and well-being for all. About the Job The Associate Director/Director, Scientific Communications will play a pivotal role in shaping and executing an integrated scientific communications strategy to support Cognito’s pipeline and future commercialization efforts. Reporting to the Head of Medical Affairs, this individual will be a key member of the Medical Affairs team, responsible for leading medical education initiatives, publication strategy, and support of the Brain Health Collaboratories. This role is central to translating complex preclinical, clinical, and real-world data into clear, accurate, and compliant communications for both internal and external stakeholders, including healthcare professionals, payers, and scientific communities. The Director will ensure timely and effective dissemination of scientific data while aligning communications with congress activities and subject matter expert (SME) engagement strategies. The position may be remote or hybrid (Cambridge, MA) and requires both strategic leadership and hands-on execution in a fast-paced, innovative environment. Roles and Responsibilities Strategic Leadership & Planning Develop and execute an integrated scientific and medical communications strategy aligned with corporate objectives and evolving standards of care. Define and lead publication planning, including identification of key data milestones, communication opportunities, and stakeholder alignment. Ensure seamless integration of communication plans with congress strategy and SME/KOL development. Scientific Communications & Content Development Translate complex scientific and clinical data into clear, compelling, and compliant communications for diverse audiences. Lead the development of medical communication materials, including: Abstracts, posters, manuscripts, and presentations Unbranded disease state education materials (e.g., slide decks, training tools) Support data dissemination across multiple platforms and audiences. Omnichannel Execution Implement omnichannel communication strategies to ensure consistent, effective delivery across digital, print, and live channels. Support and participate in scientific congresses, including presentation of data as appropriate. Cross-Functional Collaboration & Stakeholder Engagement Serve as a central point of contact for scientific communications, coordinating with internal teams, external partners, and publication authors. Build and maintain strong relationships with key opinion leaders (KOLs), investigators, and professional societies, particularly in Alzheimer’s disease and related neurodegenerative disorders. Support advisory boards, roundtables, and scientific exchange initiatives to capture external insights and inform strategy. Training & Internal Enablement Develop and deliver medical and scientific training for internal stakeholders, including commercial, clinical, and cross-functional teams. Ensure alignment and scientific rigor across all internal education initiatives. Governance, Compliance & Operations Lead Medical (MLR) review processes, along with Legal, and Regulatory partners to ensure all materials meet compliance and scientific accuracy standards. Manage external vendors and agency partners supporting medical communications. Ensure adherence to regulatory, ethical, and company standards across all activities. Qualifications & Experience Advanced degree in a relevant scientific or clinical discipline (MD, PhD, PharmD, or equivalent) preferred. 5+ years of experience in Scientific or Medical Communications within biotech, biopharma, or medical device industries; experience in neuroscience or neurodegeneration strongly preferred. Demonstrated ability to translate complex scientific data into clear, impactful narratives. Proven success in KOL engagement, publication strategy, and medical communications execution. Experience collaborating across functions and managing external partners, including academic institutions and vendors. Strong leadership, communication, and organizational skills; ability to thrive in a fast-paced, matrixed, and entrepreneurial environment. Willingness to travel (~15–20%) for scientific congresses and internal meetings.
Job Details
Location Cambridge, Massachusetts, United States
Work mode Hybrid
Employment Full-time
Department Medical Affairs
Posted 3 months ago
Application On company website
About company
Cognito Therapeutics logo

Cognito is developing novel and innovative therapeutics designed to potentially improve the lives of patients living with neurodegenerative diseases.

Founded on breakthrough research from MIT, Cognito's investigational platform, Spectris, uses non-invasive audiovisual stimulation to evoke specific brain wave activity—particularly gamma waves—with the potential to preserve brain structure, cognition, and function in patients with Alzheimer’s disease.

The company has demonstrated promising results in clinical studies, including significant slowing of disease progression in treated patients. Spectris AD has received FDA Breakthrough Device Designation, and Cognito is advancing its approach across multiple neurodegenerative conditions.

All jobs at Cognito Therapeutics Visit website